Daniel Bendheim
Vermogen: 551 380 $ op 31-07-2026
Vermogen: 551 380 $ op 31-07-2026
Daniel M.
Bendheim is currently President, Chief Executive Officer & Director at Phibro Animal Health Corp.
since 2026.
Mr. Bendheim is also Manager at BFI Co. LLC.
Education history includes an undergraduate degree from Yeshiva University conferred in 1993 and a graduate degree from Harvard Law School conferred in 1996.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-08-2026 | 15.177 ( 0,07% ) | 551 380 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PHIBRO ANIMAL HEALTH CORPORATION | Algemeen Directeur | 01-07-2026 |
BFI Co. LLC
BFI Co. LLC Financial ConglomeratesFinance Operates as an investment vehicle | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Phibro Animal Health Corp.
Phibro Animal Health Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets animal health pharmaceutical and nutritional products | Health Technology |
Yeshiva University
Yeshiva University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BFI Co. LLC
BFI Co. LLC Financial ConglomeratesFinance Operates as an investment vehicle | Finance |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau